mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection

T cell exhaustion is a state of T cell dysfunction associated with expression of programmed death 1 (PD-1). Exhausted CD8+ T cells are maintained by self-renewing stem-like T cells that provide differentiated TIM3+ cells, a part of which possesses effector-like properties. PD-1–targeted therapies en...

Cijeli opis

Bibliografski detalji
Glavni autori: Satomi Ando, Charles M. Perkins, Yamato Sajiki, Chase Chastain, Rajesh M. Valanparambil, Andreas Wieland, William H. Hudson, Masao Hashimoto, Suresh S. Ramalingam, Gordon J. Freeman, Rafi Ahmed, Koichi Araki
Format: Članak
Jezik:English
Izdano: American Society for Clinical Investigation 2023-01-01
Serija:The Journal of Clinical Investigation
Teme:
Online pristup:https://doi.org/10.1172/JCI160025
_version_ 1827768215072145408
author Satomi Ando
Charles M. Perkins
Yamato Sajiki
Chase Chastain
Rajesh M. Valanparambil
Andreas Wieland
William H. Hudson
Masao Hashimoto
Suresh S. Ramalingam
Gordon J. Freeman
Rafi Ahmed
Koichi Araki
author_facet Satomi Ando
Charles M. Perkins
Yamato Sajiki
Chase Chastain
Rajesh M. Valanparambil
Andreas Wieland
William H. Hudson
Masao Hashimoto
Suresh S. Ramalingam
Gordon J. Freeman
Rafi Ahmed
Koichi Araki
author_sort Satomi Ando
collection DOAJ
description T cell exhaustion is a state of T cell dysfunction associated with expression of programmed death 1 (PD-1). Exhausted CD8+ T cells are maintained by self-renewing stem-like T cells that provide differentiated TIM3+ cells, a part of which possesses effector-like properties. PD-1–targeted therapies enhance T cell response by promoting differentiation of stem-like T cells toward TIM3+ cells, but the role of mTOR during T cell exhaustion remains elusive. Here, we showed that mTOR inhibition has distinct outcomes during the beginning of and after the establishment of chronic viral infection. Blocking mTOR during the T cell expansion phase enhanced the T cell response by causing accumulation of stem-like T cells, leading to improved efficacy of PD-1 immunotherapy; whereas, after exhaustion progressed, mTOR inhibition caused immunosuppression, characterized by decreased TIM3+ cells and increased viral load with minimal changes in stem-like T cells. Mechanistically, a cell-intrinsic mTOR signal was vital for differentiation of stem-like T cells into the TIM3+ state in the early and late phases of chronic infection as well as during PD-1 immunotherapy. Thus, PD-1 blockade worked after cessation of mTOR inhibition, but simultaneous treatment failed to induce functional TIM3+ cells, reducing efficacy of PD-1 immunotherapy. Our data demonstrate that mTOR regulates T cell exhaustion and have important implications for combination cancer therapies with PD-1 blockade.
first_indexed 2024-03-11T12:09:12Z
format Article
id doaj.art-dfaca50a88f74b02a4c1d34e9ba0a73c
institution Directory Open Access Journal
issn 1558-8238
language English
last_indexed 2024-03-11T12:09:12Z
publishDate 2023-01-01
publisher American Society for Clinical Investigation
record_format Article
series The Journal of Clinical Investigation
spelling doaj.art-dfaca50a88f74b02a4c1d34e9ba0a73c2023-11-07T16:19:47ZengAmerican Society for Clinical InvestigationThe Journal of Clinical Investigation1558-82382023-01-011332mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infectionSatomi AndoCharles M. PerkinsYamato SajikiChase ChastainRajesh M. ValanparambilAndreas WielandWilliam H. HudsonMasao HashimotoSuresh S. RamalingamGordon J. FreemanRafi AhmedKoichi ArakiT cell exhaustion is a state of T cell dysfunction associated with expression of programmed death 1 (PD-1). Exhausted CD8+ T cells are maintained by self-renewing stem-like T cells that provide differentiated TIM3+ cells, a part of which possesses effector-like properties. PD-1–targeted therapies enhance T cell response by promoting differentiation of stem-like T cells toward TIM3+ cells, but the role of mTOR during T cell exhaustion remains elusive. Here, we showed that mTOR inhibition has distinct outcomes during the beginning of and after the establishment of chronic viral infection. Blocking mTOR during the T cell expansion phase enhanced the T cell response by causing accumulation of stem-like T cells, leading to improved efficacy of PD-1 immunotherapy; whereas, after exhaustion progressed, mTOR inhibition caused immunosuppression, characterized by decreased TIM3+ cells and increased viral load with minimal changes in stem-like T cells. Mechanistically, a cell-intrinsic mTOR signal was vital for differentiation of stem-like T cells into the TIM3+ state in the early and late phases of chronic infection as well as during PD-1 immunotherapy. Thus, PD-1 blockade worked after cessation of mTOR inhibition, but simultaneous treatment failed to induce functional TIM3+ cells, reducing efficacy of PD-1 immunotherapy. Our data demonstrate that mTOR regulates T cell exhaustion and have important implications for combination cancer therapies with PD-1 blockade.https://doi.org/10.1172/JCI160025ImmunologyInfectious disease
spellingShingle Satomi Ando
Charles M. Perkins
Yamato Sajiki
Chase Chastain
Rajesh M. Valanparambil
Andreas Wieland
William H. Hudson
Masao Hashimoto
Suresh S. Ramalingam
Gordon J. Freeman
Rafi Ahmed
Koichi Araki
mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection
The Journal of Clinical Investigation
Immunology
Infectious disease
title mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection
title_full mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection
title_fullStr mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection
title_full_unstemmed mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection
title_short mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection
title_sort mtor regulates t cell exhaustion and pd 1 targeted immunotherapy response during chronic viral infection
topic Immunology
Infectious disease
url https://doi.org/10.1172/JCI160025
work_keys_str_mv AT satomiando mtorregulatestcellexhaustionandpd1targetedimmunotherapyresponseduringchronicviralinfection
AT charlesmperkins mtorregulatestcellexhaustionandpd1targetedimmunotherapyresponseduringchronicviralinfection
AT yamatosajiki mtorregulatestcellexhaustionandpd1targetedimmunotherapyresponseduringchronicviralinfection
AT chasechastain mtorregulatestcellexhaustionandpd1targetedimmunotherapyresponseduringchronicviralinfection
AT rajeshmvalanparambil mtorregulatestcellexhaustionandpd1targetedimmunotherapyresponseduringchronicviralinfection
AT andreaswieland mtorregulatestcellexhaustionandpd1targetedimmunotherapyresponseduringchronicviralinfection
AT williamhhudson mtorregulatestcellexhaustionandpd1targetedimmunotherapyresponseduringchronicviralinfection
AT masaohashimoto mtorregulatestcellexhaustionandpd1targetedimmunotherapyresponseduringchronicviralinfection
AT sureshsramalingam mtorregulatestcellexhaustionandpd1targetedimmunotherapyresponseduringchronicviralinfection
AT gordonjfreeman mtorregulatestcellexhaustionandpd1targetedimmunotherapyresponseduringchronicviralinfection
AT rafiahmed mtorregulatestcellexhaustionandpd1targetedimmunotherapyresponseduringchronicviralinfection
AT koichiaraki mtorregulatestcellexhaustionandpd1targetedimmunotherapyresponseduringchronicviralinfection